OncoMed Pharmaceuticals, Inc.
     
 
 

Management

John Lewicki, Ph.D.
President and Chief Executive Officer, OncoMed Pharmaceuticals
Austin Gurney, Ph.D.
Chief Scientific Officer, Senior Vice President, Research
Alicia J. Hager, J.D., Ph.D.
Senior Vice President and General Counsel
Robert Stagg, Pharm.D.
Senior Vice President, Clinical Research and Development
Yvonne Li
Vice President of Finance, Controller and Administration
Leonardo Faoro, MD, MBA
Vice President, Clinical Development
Jill Henrich
Vice President, Regulatory Affairs
Ann Kapoun, Ph.D.
Vice President, Translational Medicine
Stock Quote (NASDAQ: OMED)
Price:
2.80
Change:
+ 0.02
Day High:
2.85
Day Low:
2.75
Volume:
104,193
4:00 PM ET on May 25, 2018
Delayed at least 20 minutes.
Provided by eSignal.
Search Investor Relations